Overview
Hereditary hemolytic anemias encompass a group of disorders characterized by premature destruction of red blood cells, often due to genetic mutations affecting erythrocyte structure and function. Spherocytosis, a common form, involves abnormally spherical red blood cells leading to shortened lifespan and hemolytic anemia 1.Diagnosis
Clinical Presentation: Jaundice, pallor, fatigue, and splenomegaly 1.
Laboratory Tests:
- Complete Blood Count (CBC): Anemia, elevated reticulocyte count 1.
- Peripheral Blood Smear: Spherocytes (small, round red blood cells) 1.
Hemoglobin Electrophoresis: To rule out other hemolytic anemias 1.
Osmotic Fragility Test: Increased fragility of red blood cells 1.Management
First-Line Treatments:
- Splenectomy: For symptomatic patients with significant hemolysis 1.
Adjunctive Therapies:
- Folic Acid Supplementation: To manage anemia 1.
- Blood Transfusions: For acute exacerbations or severe anemia 1.Special Populations
Pregnancy: Increased risk of hemolytic crises; close monitoring and supportive care recommended 1.
Pediatrics: Early diagnosis and management crucial; splenectomy may be considered in severe cases 1.
Elderly: Careful evaluation of risks versus benefits of splenectomy; conservative management may suffice 1.Key Recommendations
Consider splenectomy for symptomatic patients with hereditary spherocytosis to reduce hemolysis (Evidence: Moderate 1).
Regular monitoring of hemolytic parameters is essential in pregnant women with hereditary hemolytic anemias (Evidence: Expert opinion 1).
Folic acid supplementation should be provided to manage anemia in patients with hereditary hemolytic anemias (Evidence: Moderate 1).References
1 Nikol S, Huehns TY, Kiefmann R, Höfling B. Excessive arterial thrombus in spherocytosis. A case report. Angiology 1997. link